Drug Type Fusion protein |
Synonyms PD-L1 Affimer/IL2 bispecific(Avacta) |
Target |
Mechanism IL-2 replacements(Interleukin-2 replacements), PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | - | - |